Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 29 June 2009, doi:10.1136/bmj.b1307
Cite this as: BMJ 2009;338:b1307
More accurate measures of kidney function are needed to identify those at risk
| The first 150 words of the full text of this article appear below. |
Several studies have shown that people with impaired kidney function are at higher risk of cardiovascular disease and death,1 2 although the reasons for this are unclear. In the linked study (doi:10.1136/bmj.b2392), Kurth and colleagues examine data from female health professionals aged 45 and over enrolled in the Womens Health Study (WHS) to assess the association of kidney function with cardiovascular disease and mortality.3
The WHS is a randomised trial of low dose aspirin and vitamin E supplements conducted in nearly 40 000 relatively healthy, predominantly white, female healthcare professionals in the United States. Serum creatinine was assayed in 27 939 participants using a rate blanked method based on the Jaffé reaction, and estimated glomerular filtration rate (GFR) was calculated with the four-variable Modification of Diet in Renal Disease Study (MDRD) equation. Over a mean of 12 years, 1199 cardiovascular events and 856 deaths occurred. When compared with an
Daniel E Weiner, assistant professor , Dena E Rifkin, instructor
1 Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
dweiner@tuftsmedicalcenter.org
Read all Rapid Responses